KDM4A and breast cancer: To determine whether the expression level of JMJD2A was associated with progression of breast cancer, we initially examined JMJD2A expression in four breast cancer cell lines, including two weakly metastatic cell lines (MCF-7 and T47D) and two highly metastatic cell lines (MDA-MB-231 and SUM1315).